Professional pharmacy services for improving public health and smoking cessation

Added June 23, 2020

Citation: Perraudin C, Bugnon O, Pelletier-Fleury N. Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations. Health Policy 2016;120:1350-1362.

Free to view: No

What is this? The COVID-19 pandemic is placing a great strain on healthcare services and resources. Existing research on the use of community pharmacists to expand professional pharmacy services might provide useful information for policy makers.

In this systematic review, the authors searched for European research evaluating the effectiveness and cost-effectiveness of professional pharmacy services. They did not restrict by type of publication, but limited their search to publications in English between 2004 and 2015. They included 21 studies, which were conducted in Belgium (1 study), Denmark (1), France (1), the Netherlands (3), Spain (2) and the UK (13).

What was found: Professional pharmacy services are likely to be effective in improving public health outcomes, in particular relating to health screening and smoking cessation.

The effects of professional pharmacy services for enhancing medicine safety and access, improving medical outcomes of individual patients and contributing to the quality and efficiency of health systems were mixed and inconclusive.


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.